Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Benign Frontal Childhood Epilepsy

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Benign Frontal Childhood Epilepsy in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avoli, M1
Bernasconi, A1
Mattia, D1
Olivier, A1
Hwa, GG1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Benign Frontal Childhood Epilepsy

ArticleYear
Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology.
    Annals of neurology, 1999, Volume: 46, Issue:6

    Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; Anticonvulsants; Cerebral

1999